TickerFactsScreenerDevelopers

Celldex Therapeutics, Inc. (CLDX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $18.13M2009: $73.77M2010: $75.25M2011: $68.72M2012: $95.77M2013: $319.80M2014: $211.66M2015: $290.11M2016: $265.43M2017: $236.37M2018: $124.06M2019: $94.03M2020: $209.36M2021: $419.48M2022: $326.20M2023: $429.17M2024: $747.00M2025: $527.16M$527.16M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$527.16M-29.4%
2024$747.00M+74.1%
2023$429.17M+31.6%
2022$326.20M-22.2%
2021$419.48M+100.4%
2020$209.36M+122.7%
2019$94.03M-24.2%
2018$124.06M-47.5%
2017$236.37M-10.9%
2016$265.43M-8.5%
2015$290.11M+37.1%
2014$211.66M-33.8%
2013$319.80M+233.9%
2012$95.77M+39.4%
2011$68.72M-8.7%
2010$75.25M+2.0%
2009$73.77M+306.8%
2008$18.13M—